Hansoh Pharmaceutical (03692) Grants Restricted Share Units Representing 4,992,300 Shares

Hansoh Pharma (03692) announced that, on April 28, 2026, a total of restricted share units representing 4,992,300 shares were granted to 804 grantees under the Restricted Share Unit Plan adopted by the company on May 27, 2019, following its initial public offering, subject to the acceptance by the grantees.